Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Corum Group Limited ( (AU:PHX) ) has shared an announcement.
Pharmx Technologies Limited reported record revenues of $7.5 million for the fiscal year ending June 2025, marking a 13% increase from the previous year. Despite a 13% decline in EBITDA due to significant investments in development and infrastructure, the company maintained a strong cash position of $4.2 million. Key operational highlights include a 16% increase in supplier partners and strategic partnerships, notably with Toniq in New Zealand, which significantly expanded Pharmx’s market reach. The company’s focus on expanding its Marketplace and Gateway services resulted in substantial growth in processed invoice values and order numbers, positioning Pharmx for sustained future growth.
More about Corum Group Limited
Pharmx Technologies Limited operates in the pharmaceutical technology industry, focusing on providing a range of digital solutions for pharmacies and suppliers. The company is known for its development of platforms that facilitate transactions and partnerships within the pharmaceutical sector, with a strong market presence in Australia and New Zealand.
Average Trading Volume: 650,485
Technical Sentiment Signal: Buy
Current Market Cap: A$65.84M
For a thorough assessment of PHX stock, go to TipRanks’ Stock Analysis page.